{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:19:20Z","timestamp":1792819160733,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["CYRE - No. 340941"],"award-info":[{"award-number":["CYRE - No. 340941"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-15-CE14-0025"],"award-info":[{"award-number":["ANR-15-CE14-0025"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0071"],"award-info":[{"award-number":["ANR-11-LABX-0071"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00018-019-03004-9","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T05:27:28Z","timestamp":1547789248000},"page":"1201-1214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A novel leptin receptor antagonist uncouples leptin\u2019s metabolic and immune functions"],"prefix":"10.1007","volume":"76","author":[{"given":"Lennart","family":"Zabeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Wauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Van Lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elianne","family":"Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"De Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Rogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Jockers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"3004_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199602013340503","volume":"334","author":"RV Considine","year":"1996","unstructured":"Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292\u2013295","journal-title":"N Engl J Med"},{"key":"3004_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"M Maffei","year":"1995","unstructured":"Maffei M, Halaas J, Ravussin E et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155\u20131161","journal-title":"Nat Med"},{"key":"3004_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763\u2013770. \n                    https:\/\/doi.org\/10.1038\/27376","journal-title":"Nature"},{"key":"3004_CR4","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/S0960-9822(02)70684-2","volume":"6","author":"BD Bennett","year":"1996","unstructured":"Bennett BD, Solar GP, Yuan JQ et al. (1996) A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 6:1170\u20131180. \n                    https:\/\/doi.org\/10.1016\/S0960-9822(02)70684-2","journal-title":"Curr Biol"},{"key":"3004_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2018.00640","volume":"9","author":"V Francisco","year":"2018","unstructured":"Francisco V, Pino J, Campos-cabaleiro V et al (2018) Obesity, fat mass and immune system: role for leptin. Front Physiol 9:1\u201320. \n                    https:\/\/doi.org\/10.3389\/fphys.2018.00640","journal-title":"Front Physiol"},{"key":"3004_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molmed.2015.12.001","volume":"22","author":"C Naylor","year":"2016","unstructured":"Naylor C, Petri WA (2016) Leptin regulation of immune responses. Trends Mol Med 22:88\u201398. \n                    https:\/\/doi.org\/10.1016\/j.molmed.2015.12.001","journal-title":"Trends Mol Med"},{"key":"3004_CR7","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.biochi.2012.05.018","volume":"94","author":"F Carbone","year":"2012","unstructured":"Carbone F, La Rocca C, Matarese G (2012) Immunological functions of leptin and adiponectin. Biochimie 94:2082\u20132088. \n                    https:\/\/doi.org\/10.1016\/j.biochi.2012.05.018","journal-title":"Biochimie"},{"key":"3004_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbi.2008.10.007","volume":"23","author":"G Fantuzzi","year":"2009","unstructured":"Fantuzzi G (2009) Three questions about leptin and immunity. Brain Behav Immun 23:405\u2013410. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2008.10.007","journal-title":"Brain Behav Immun"},{"key":"3004_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/hsz-2013-0283","volume":"395","author":"L Zabeau","year":"2014","unstructured":"Zabeau L, Peelman F, Tavernier J (2014) Antagonising leptin: current status and future directions. Biol Chem 395:499\u2013514. \n                    https:\/\/doi.org\/10.1515\/hsz-2013-0283","journal-title":"Biol Chem"},{"key":"3004_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/ng0396-318","volume":"12","author":"FF Chehab","year":"1996","unstructured":"Chehab FF, Lim ME, Lu R (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12:318\u2013320. \n                    https:\/\/doi.org\/10.1038\/ng0396-318","journal-title":"Nat Genet"},{"issue":"5","key":"3004_CR11","doi-asserted-by":"publisher","first-page":"E335","DOI":"10.1152\/ajpendo.00312.2014","volume":"308","author":"JF Briffa","year":"2015","unstructured":"Briffa JF, McAinch AJ, Romano T et al (2015) Leptin in pregnancy and development: a contributor to adulthood disease? Am J Physiol Endocrinol Metab 308(5):E335\u2013E350. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00312.2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3004_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","volume":"281","author":"MR Sierra-Honigmann","year":"1998","unstructured":"Sierra-Honigmann MR, Nath AK, Murakami C et al (1998) Biological action of leptin as an angiogenic factor. Science 281:1683\u20131686","journal-title":"Science"},{"key":"3004_CR13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1172\/JCI13143","volume":"108","author":"S Konstantinides","year":"2001","unstructured":"Konstantinides S, Schafer K, Koschnick S, Loskutoff D (2001) Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108:1533\u20131540","journal-title":"J Clin Invest"},{"key":"3004_CR14","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1097\/00004872-199917121-00026","volume":"17","author":"AL Mark","year":"1999","unstructured":"Mark AL, Shaffer RA, Correia ML et al (1999) Contrasting blood pressure effects of obesity in leptin-deficient ob\/ob mice and agouti yellow obese mice. J Hypertens 17:1949\u20131953","journal-title":"J Hypertens"},{"key":"3004_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","volume":"100","author":"P Ducy","year":"2000","unstructured":"Ducy P, Amling M, Takeda S et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197\u2013207","journal-title":"Cell"},{"key":"3004_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI0215693","volume":"110","author":"IS Farooqi","year":"2002","unstructured":"Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093\u20131103. \n                    https:\/\/doi.org\/10.1172\/JCI15693","journal-title":"J Clin Invest"},{"key":"3004_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1471-4906(02)02188-9","volume":"23","author":"G Matarese","year":"2002","unstructured":"Matarese G, La Cava A, Sanna V et al (2002) Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol 23:182\u2013187","journal-title":"Trends Immunol"},{"key":"3004_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.dci.2016.06.006","volume":"66","author":"C Procaccini","year":"2017","unstructured":"Procaccini C, La C, Carbone F et al (2017) Leptin as immune mediator: interaction between neuroendocrine and immune system. Dev Comp Immunol 66:120\u2013129. \n                    https:\/\/doi.org\/10.1016\/j.dci.2016.06.006","journal-title":"Dev Comp Immunol"},{"key":"3004_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/mnfr.200700050","volume":"52","author":"K Karmiris","year":"2008","unstructured":"Karmiris K, Koutroubakis IE, Kouroumalis EA (2008) Leptin, adiponectin, resistin, and ghrelin\u2013implications for inflammatory bowel disease. Mol Nutr Food Res 52:855\u2013866. \n                    https:\/\/doi.org\/10.1002\/mnfr.200700050","journal-title":"Mol Nutr Food Res"},{"key":"3004_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/01.mib.0000178915.54264.8f","volume":"11","author":"K Karmiris","year":"2005","unstructured":"Karmiris K, Koutroubakis IE, Kouroumalis EA (2005) The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflamm Bowel Dis 11:847\u2013855. \n                    https:\/\/doi.org\/10.1097\/01.mib.0000178915.54264.8f","journal-title":"Inflamm Bowel Dis"},{"key":"3004_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2018.03.011","volume":"423","author":"L Navarini","year":"2018","unstructured":"Navarini L, Margiotta DPE, Vadacca M, Afeltra A (2018) Leptin in autoimmune mechanisms of systemic rheumatic diseases. Cancer Lett 423:139\u2013146. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2018.03.011","journal-title":"Cancer Lett"},{"key":"3004_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4049\/jimmunol.168.2.875","volume":"168","author":"N Busso","year":"2002","unstructured":"Busso N, So A, Chobaz-Peclat V et al (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168:875\u2013882","journal-title":"J Immunol"},{"key":"3004_CR23","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.4049\/jimmunol.166.10.5909","volume":"166","author":"G Matarese","year":"2001","unstructured":"Matarese G, Di Giacomo A, Sanna V et al (2001) Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166:5909\u20135916","journal-title":"J Immunol"},{"key":"3004_CR24","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1073\/pnas.0408995102","volume":"102","author":"G Matarese","year":"2005","unstructured":"Matarese G, Carrieri PB, La Cava A et al (2005) Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25\u2009+\u2009regulatory T cells. Proc Natl Acad Sci USA 102:5150\u20135155. \n                    https:\/\/doi.org\/10.1073\/pnas.0408995102","journal-title":"Proc Natl Acad Sci USA"},{"key":"3004_CR25","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1073\/pnas.040561297","volume":"97","author":"R Faggioni","year":"2000","unstructured":"Faggioni R, Jones-Carson J, Reed DA et al (2000) Leptin-deficient (ob\/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci USA 97:2367\u20132372. \n                    https:\/\/doi.org\/10.1073\/pnas.040561297040561297","journal-title":"Proc Natl Acad Sci USA"},{"key":"3004_CR26","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1210\/en.2004-1572","volume":"146","author":"JA Sennello","year":"2005","unstructured":"Sennello JA, Fayad R, Morris AM et al (2005) Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology 146:2157\u20132164. \n                    https:\/\/doi.org\/10.1210\/en.2004-1572","journal-title":"Endocrinology"},{"key":"3004_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/1521-4141(200202)32:2<552::AID-IMMU552>3.0.CO;2-H","volume":"32","author":"B Siegmund","year":"2002","unstructured":"Siegmund B, Lear-Kaul KC, Faggioni R, Fantuzzi G (2002) Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur J Immunol 32:552\u2013560","journal-title":"Eur J Immunol"},{"key":"3004_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jcp.20472","volume":"207","author":"C Garofalo","year":"2006","unstructured":"Garofalo C, Surmacz E (2006) Leptin and cancer. J Cell Physiol 207:12\u201322. \n                    https:\/\/doi.org\/10.1002\/jcp.20472","journal-title":"J Cell Physiol"},{"key":"3004_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1517\/14728221003716466","volume":"14","author":"A Ray","year":"2010","unstructured":"Ray A, Cleary MP (2010) Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets 14:443\u2013451. \n                    https:\/\/doi.org\/10.1517\/14728221003716466","journal-title":"Expert Opin Ther Targets"},{"key":"3004_CR30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jcb.21911","volume":"105","author":"D Cirillo","year":"2008","unstructured":"Cirillo D, Rachiglio AM, la Montagna R et al (2008) Leptin signaling in breast cancer: an overview. J Cell Biochem 105:956\u2013964. \n                    https:\/\/doi.org\/10.1002\/jcb.21911","journal-title":"J Cell Biochem"},{"key":"3004_CR31","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.3748\/wjg.15.5141","volume":"15","author":"R Pais","year":"2009","unstructured":"Pais R, Silaghi H, Silaghi A-C et al (2009) Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 15:5141\u20135148","journal-title":"World J Gastroenterol"},{"key":"3004_CR32","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/oby.20138","volume":"21","author":"LM Liao","year":"2013","unstructured":"Liao LM, Schwartz K, Pollak M et al (2013) Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring) 21:1478\u20131485. \n                    https:\/\/doi.org\/10.1002\/oby.20138","journal-title":"Obesity (Silver Spring)"},{"key":"3004_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/leu.2017.146","volume":"146","author":"M Favreau","year":"2017","unstructured":"Favreau M, Menu E, Gaublomme D et al (2017) Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma. Leukemia 146:1\u20138. \n                    https:\/\/doi.org\/10.1038\/leu.2017.146","journal-title":"Leukemia"},{"key":"3004_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/annonc\/mdm464","volume":"19","author":"H Gogas","year":"2008","unstructured":"Gogas H, Trakatelli M, Dessypris N et al (2008) Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol 19:384\u2013389. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdm464","journal-title":"Ann Oncol"},{"key":"3004_CR35","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","volume":"83","author":"LA Tartaglia","year":"1995","unstructured":"Tartaglia LA, Dembski M, Weng X et al (1995) Identification and expression cloning of a leptin receptor. Cell 83:1263\u20131271. \n                    https:\/\/doi.org\/10.1016\/0092-8674(95)90151-5","journal-title":"Cell"},{"key":"3004_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1124\/mol.53.2.234","volume":"53","author":"TM Fong","year":"1998","unstructured":"Fong TM, Huang RR, Tota MR et al (1998) Localization of leptin binding domain in the leptin receptor. Mol Pharmacol 53:234\u2013240","journal-title":"Mol Pharmacol"},{"key":"3004_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1210\/me.2003-0078","volume":"18","author":"L Zabeau","year":"2004","unstructured":"Zabeau L, Defeau D, Van der Heyden J et al (2004) Functional analysis of leptin receptor activation using a Janus kinase\/signal transducer and activator of transcription complementation assay. Mol Endocrinol 18:150\u2013161. \n                    https:\/\/doi.org\/10.1210\/Me.2003-0078","journal-title":"Mol Endocrinol"},{"key":"3004_CR38","doi-asserted-by":"publisher","first-page":"41038","DOI":"10.1074\/jbc.M404962200","volume":"279","author":"F Peelman","year":"2004","unstructured":"Peelman F, Van Beneden K, Zabeau L et al (2004) Mapping of the leptin binding sites and design of a leptin antagonist. J Biol Chem 279:41038\u201341046. \n                    https:\/\/doi.org\/10.1074\/jbc.M404962200","journal-title":"J Biol Chem"},{"key":"3004_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1042\/BJ20050457","volume":"391","author":"L Niv-Spector","year":"2005","unstructured":"Niv-Spector L, Gonen-Berger D, Gourdou I et al (2005) Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem J 391:221\u2013230. \n                    https:\/\/doi.org\/10.1042\/bj20050457","journal-title":"Biochem J"},{"key":"3004_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1210\/mend.11.4.9907","volume":"11","author":"N Ghilardi","year":"1997","unstructured":"Ghilardi N, Skoda RC (1997) The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 11:393\u2013399","journal-title":"Mol Endocrinol"},{"key":"3004_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fendo.2017.00030","volume":"8","author":"J Wauman","year":"2017","unstructured":"Wauman J, Zabeau L, Tavernier J (2017) The leptin receptor complex: heavier than expected? Front Endocrinol (Lausanne) 8:30. \n                    https:\/\/doi.org\/10.3389\/fendo.2017.00030","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3004_CR42","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.2741\/3885","volume":"16","author":"J Wauman","year":"2011","unstructured":"Wauman J, Tavernier J (2011) Leptin receptor signaling: pathways to leptin resistance. Front Biosci 16:2771\u20132793. \n                    https:\/\/doi.org\/10.2741\/3885","journal-title":"Front Biosci"},{"key":"3004_CR43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00018-014-1697-x","volume":"72","author":"L Zabeau","year":"2015","unstructured":"Zabeau L, Jensen CJ, Seeuws S et al (2015) Leptin\u2019s metabolic and immune functions can be uncoupled at the ligand\/receptor interaction level. Cell Mol Life Sci 72:629\u2013644. \n                    https:\/\/doi.org\/10.1007\/s00018-014-1697-x","journal-title":"Cell Mol Life Sci"},{"key":"3004_CR44","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/1541-7786.MCR-07-2126","volume":"6","author":"T Ozbay","year":"2008","unstructured":"Ozbay T, Nahta R (2008) A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells. Mol Cancer Res 6:1052\u20131058. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-2126","journal-title":"Mol Cancer Res"},{"key":"3004_CR45","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1158\/0008-5472.CAN-08-1952","volume":"68","author":"NK Saxena","year":"2008","unstructured":"Saxena NK, Taliaferro-Smith L, Knight BB et al (2008) Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res 68:9712\u20139722. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1952","journal-title":"Cancer Res"},{"key":"3004_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejphar.2007.06.051","volume":"573","author":"H-H Chao","year":"2007","unstructured":"Chao H-H, Hong H-J, Liu J-C et al (2007) Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Eur J Pharmacol 573:49\u201354. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2007.06.051","journal-title":"Eur J Pharmacol"},{"key":"3004_CR47","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1210\/en.2006-0224","volume":"147","author":"O Ogunwobi","year":"2006","unstructured":"Ogunwobi O, Mutungi G, Beales ILP (2006) Leptin stimulates proliferation and inhibits apoptosis in Barrett\u2019s esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147:4505\u20134516. \n                    https:\/\/doi.org\/10.1210\/en.2006-0224","journal-title":"Endocrinology"},{"key":"3004_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1677\/ERC-09-0340","volume":"17","author":"R Fusco","year":"2010","unstructured":"Fusco R, Galgani M, Procaccini C et al (2010) Cellular and molecular crosstalk between leptin receptor and estrogen receptor alpha in breast cancer: molecular basis for a novel therapeutic setting. Endocr Relat Cancer 17:373\u2013382. \n                    https:\/\/doi.org\/10.1677\/ERC-09-0340","journal-title":"Endocr Relat Cancer"},{"key":"3004_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ijc.25010","volume":"127","author":"NA Binai","year":"2010","unstructured":"Binai NA, Damert A, Carra G et al (2010) Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells. Int J Cancer 127:55\u201366. \n                    https:\/\/doi.org\/10.1002\/ijc.25010","journal-title":"Int J Cancer"},{"key":"3004_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/BJ20110438","volume":"441","author":"L Zabeau","year":"2012","unstructured":"Zabeau L, Verhee A, Catteeuw D et al (2012) Selection of non-competitive leptin antagonists using a random nanobody-based approach. Biochem J 441:425\u2013434. \n                    https:\/\/doi.org\/10.1042\/BJ20110438","journal-title":"Biochem J"},{"key":"3004_CR51","first-page":"78","volume":"13","author":"D Broekaert","year":"2002","unstructured":"Broekaert D, Eyckerman S, Lavens D et al (2002) Comparison of leptin- and interleukin-6-regulated expression of the rPAP gene family: evidence for differential co-regulatory signals. Eur Cytokine Netw 13:78\u201385","journal-title":"Eur Cytokine Netw"},{"key":"3004_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2012.12.013","volume":"436","author":"V Vauthier","year":"2013","unstructured":"Vauthier V, Derviaux C, Douayry N et al (2013) Design and validation of a homogeneous time-resolved fluorescence-based leptin receptor binding assay. Anal Biochem 436:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ab.2012.12.013","journal-title":"Anal Biochem"},{"key":"3004_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fendo.2012.00092","volume":"3","author":"M Cottet","year":"2012","unstructured":"Cottet M, Faklaris O, Maurel D et al (2012) BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues. Front Endocrinol (Lausanne) 3:92. \n                    https:\/\/doi.org\/10.3389\/fendo.2012.00092","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3004_CR54","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1074\/mcp.M114.041087","volume":"13","author":"S Lievens","year":"2014","unstructured":"Lievens S, Gerlo S, Lemmens I et al (2014) Kinase substrate sensor (KISS), a Mammalian in situ protein interaction sensor. Mol Cell Proteomics 13:3332\u20133342","journal-title":"Mol Cell Proteomics"},{"key":"3004_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1365-2249.2002.01797.x","volume":"128","author":"Y Fujita","year":"2002","unstructured":"Fujita Y, Murakami M, Ogawa Y et al (2002) Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 128:21\u201326","journal-title":"Clin Exp Immunol"},{"key":"3004_CR56","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.1523\/JNEUROSCI.6562-10.2011","volume":"31","author":"M Tanaka","year":"2011","unstructured":"Tanaka M, Suganami T, Kim-Saijo M et al (2011) Role of central leptin signaling in the starvation-induced alteration of B-cell development. J Neurosci 31:8373\u20138380. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.6562-10.2011","journal-title":"J Neurosci"},{"key":"3004_CR57","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/29795","volume":"394","author":"GM Lord","year":"1998","unstructured":"Lord GM, Matarese G, Howard JK et al (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897\u2013901. \n                    https:\/\/doi.org\/10.1038\/29795","journal-title":"Nature"},{"key":"3004_CR58","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1172\/JCI6762","volume":"104","author":"JK Howard","year":"1999","unstructured":"Howard JK, Lord GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob\/ob mice. J Clin Invest 104:1051\u20131059. \n                    https:\/\/doi.org\/10.1172\/JCI6762","journal-title":"J Clin Invest"},{"key":"3004_CR59","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1126\/science.283.5404.987","volume":"283","author":"O Livnah","year":"1999","unstructured":"Livnah O, Stura EA, Middleton SA et al (1999) Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283:987\u2013990","journal-title":"Science"},{"key":"3004_CR60","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.1073\/pnas.152294299","volume":"99","author":"J Gent","year":"2002","unstructured":"Gent J, van Kerkhof P, Roza M et al (2002) Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858\u20139863. \n                    https:\/\/doi.org\/10.1073\/pnas.152294299","journal-title":"Proc Natl Acad Sci USA"},{"key":"3004_CR61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0014-5793(03)00154-6","volume":"538","author":"B Schuster","year":"2003","unstructured":"Schuster B, Meinert W, Rose-John S, Kallen K-J (2003) The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane. FEBS Lett 538:113\u2013116","journal-title":"FEBS Lett"},{"key":"3004_CR62","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1242\/jcs.033399","volume":"121","author":"R-H Tao","year":"2008","unstructured":"Tao R-H, Maruyama IN (2008) All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J Cell Sci 121:3207\u20133217. \n                    https:\/\/doi.org\/10.1242\/jcs.033399","journal-title":"J Cell Sci"},{"key":"3004_CR63","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1091\/mbc.01-08-0411","volume":"13","author":"X Yu","year":"2002","unstructured":"Yu X, Sharma KD, Takahashi T et al (2002) Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol Biol Cell 13:2547\u20132557. \n                    https:\/\/doi.org\/10.1091\/mbc.01-08-0411","journal-title":"Mol Biol Cell"},{"key":"3004_CR64","doi-asserted-by":"publisher","first-page":"26604","DOI":"10.1074\/jbc.M302002200","volume":"278","author":"C Couturier","year":"2003","unstructured":"Couturier C, Jockers R (2003) Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers. J Biol Chem 278:26604\u201326611. \n                    https:\/\/doi.org\/10.1074\/jbc.M302002200M302002200","journal-title":"J Biol Chem"},{"key":"3004_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1431927605505907","volume":"11","author":"VK Ramanujan","year":"2005","unstructured":"Ramanujan VK, Biener E, Charlier M et al (2005) Quantitative FRET imaging of leptin receptor oligomerization kinetics in single cells. Microsc Microanal 11:11\u201312. \n                    https:\/\/doi.org\/10.1017\/S1431927605505907","journal-title":"Microsc Microanal"},{"key":"3004_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0014-5793(97)00013-6","volume":"403","author":"K Nakashima","year":"1997","unstructured":"Nakashima K, Narazaki M, Taga T (1997) Leptin receptor (OB-R) oligomerizes with itself but not with its closely related cytokine signal transducer gp130. FEBS Lett 403:79\u201382","journal-title":"FEBS Lett"},{"key":"3004_CR67","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/(SICI)1097-4644(19990501)73:2<278::AID-JCB13>3.0.CO;2-W","volume":"73","author":"DW White","year":"1999","unstructured":"White DW, Tartaglia LA (1999) Evidence for ligand-independent homo-oligomerization of leptin receptor (OB-R) isoforms: a proposed mechanism permitting productive long-form signaling in the presence of excess short-form expression. J Cell Biochem 73:278\u2013288","journal-title":"J Cell Biochem"},{"key":"3004_CR68","doi-asserted-by":"publisher","first-page":"22632","DOI":"10.1074\/jbc.M413308200","volume":"280","author":"L Zabeau","year":"2005","unstructured":"Zabeau L, Defeau D, Iserentant H et al (2005) Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains. J Biol Chem 280:22632\u201322640. \n                    https:\/\/doi.org\/10.1074\/jbc.m413308200","journal-title":"J Biol Chem"},{"key":"3004_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.febslet.2004.03.089","volume":"565","author":"A Eisenberg","year":"2004","unstructured":"Eisenberg A, Biener E, Charlier M et al (2004) Transactivation of erbB2 by short and long isoforms of leptin receptors. FEBS Lett 565:139\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2004.03.089","journal-title":"FEBS Lett"},{"key":"3004_CR70","doi-asserted-by":"publisher","first-page":"616","DOI":"10.2174\/138161282004140213155050","volume":"20","author":"J Beltowski","year":"2014","unstructured":"Beltowski J, Jazmroz-Wisniewska A (2014) Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapy. Curr Pharm Des 20:616\u2013624","journal-title":"Curr Pharm Des"},{"key":"3004_CR71","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1016\/j.bmcl.2017.07.002","volume":"27","author":"M K\u00f6se","year":"2017","unstructured":"K\u00f6se M (2017) GPCRs and EGFR\u2014cross-talk of membrane receptors in cancer. Bioorg Med Chem Lett 27:3611\u20133620. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2017.07.002","journal-title":"Bioorg Med Chem Lett"},{"key":"3004_CR72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ijms17010095","volume":"17","author":"Z Wang","year":"2016","unstructured":"Wang Z (2016) Transactivation of epidermal growth factor receptor by G protein-coupled receptors: recent progress, challenges and future research. Int J Mol Sci 17:95. \n                    https:\/\/doi.org\/10.3390\/ijms17010095","journal-title":"Int J Mol Sci"},{"key":"3004_CR73","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/onc.2013.74","volume":"33","author":"H Yamaguchi","year":"2014","unstructured":"Yamaguchi H, Chang S-S, Hsu JL, Hung M-C (2014) Signaling cross-talk in the resistance to HER family receptor targeted therapy. Oncogene 33:1073\u20131081. \n                    https:\/\/doi.org\/10.1038\/onc.2013.74","journal-title":"Oncogene"},{"key":"3004_CR74","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.12688\/f1000research.9025.1","volume":"5","author":"B Singh","year":"2016","unstructured":"Singh B, Carpenter G, Coffey RJ (2016) EGF receptor ligands: recent advances. F1000Res 5:2270. \n                    https:\/\/doi.org\/10.12688\/f1000research.9025.1","journal-title":"F1000Res"},{"key":"3004_CR75","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","volume":"79","author":"R Roskoski","year":"2014","unstructured":"Roskoski R (2014) The ErbB\/HER family of protein-tyrosine kinases and cancer. Pharmacol Res 79:34\u201374. \n                    https:\/\/doi.org\/10.1016\/J.PHRS.2013.11.002","journal-title":"Pharmacol Res"},{"key":"3004_CR76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","volume":"9","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z (2017) Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers (Basal) 9:52. \n                    https:\/\/doi.org\/10.3390\/cancers9050052","journal-title":"Cancers (Basal)"},{"key":"3004_CR77","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-03-0749","volume":"10","author":"M Ishikawa","year":"2004","unstructured":"Ishikawa M, Kitayama J, Nagawa H (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10:4325\u20134331","journal-title":"Clin Cancer Res"},{"key":"3004_CR78","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1530\/ERC-11-0075","volume":"18","author":"BB Knight","year":"2011","unstructured":"Knight BB, Oprea-Ilies GM, Nagalingam A et al (2011) Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. Endocr Relat Cancer 18:413\u2013428. \n                    https:\/\/doi.org\/10.1530\/ERC-11-0075","journal-title":"Endocr Relat Cancer"},{"key":"3004_CR79","doi-asserted-by":"publisher","first-page":"T63","DOI":"10.1530\/JOE-14-0480","volume":"223","author":"IS Farooqi","year":"2014","unstructured":"Farooqi IS, O\u2019Rahilly S (2014) 20 years of leptin: human disorders of leptin action. J Endocrinol 223:T63\u2013T70. \n                    https:\/\/doi.org\/10.1530\/JOE-14-0480","journal-title":"J Endocrinol"},{"key":"3004_CR80","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1210\/en.2011-0185","volume":"152","author":"J Levi","year":"2011","unstructured":"Levi J, Gray SL, Speck M et al (2011) Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance. Endocrinology 152:3385\u20133395","journal-title":"Endocrinology"},{"key":"3004_CR81","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1200\/JCO.2009.27.6360","volume":"28","author":"RL Ferris","year":"2010","unstructured":"Ferris RL, Jaffee EM, Ferrone S (2010) Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape. J Clin Oncol 28:4390\u20134399. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.27.6360","journal-title":"J Clin Oncol"},{"key":"3004_CR82","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archopht.119.3.373","volume":"119","author":"AG Scholes","year":"2001","unstructured":"Scholes AG, Hagan S, Hiscott P et al (2001) Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma. Arch Ophthalmol 119:373\u2013377","journal-title":"Arch Ophthalmol"},{"key":"3004_CR83","doi-asserted-by":"publisher","first-page":"22369","DOI":"10.1073\/pnas.0908787106","volume":"106","author":"G Chan","year":"2009","unstructured":"Chan G, Nogalski MT, Yurochko AD (2009) Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility. Proc Natl Acad Sci USA 106:22369\u201322374. \n                    https:\/\/doi.org\/10.1073\/pnas.0908787106","journal-title":"Proc Natl Acad Sci USA"},{"key":"3004_CR84","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1038\/sj.onc.1208536","volume":"24","author":"K Mahtouk","year":"2005","unstructured":"Mahtouk K, Hose D, R\u00e8me T et al (2005) Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene 24:3512\u20133524. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1208536","journal-title":"Oncogene"},{"key":"3004_CR85","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.immuni.2012.09.023","volume":"38","author":"DMW Zaiss","year":"2013","unstructured":"Zaiss DMW, van Loosdregt J, Gorlani A et al (2013) Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity 38:275\u2013284. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2012.09.023","journal-title":"Immunity"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03004-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T19:23:49Z","timestamp":1579289029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03004-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}